You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023160021
Dec 20233205
Jan 20241502
Feb 20244600
Mar 202456011
Apr 20245005
May 20243200
Jun 20242002
Jul 20244005
Aug 20242006
Sep 20242201
Oct 20243006
Nov 202452015
Dec 202440015
Jan 202547011
Feb 20251005
Mar 2025002
Apr 2025002
May 2025003
Jun 2025006
Total6720123